-
Investor Relations
- Corporate Governance
- Investor Presentations
- LIBOR Transition
- Compliance and AML
- Sustainability
- Financial Information
- Shareholders Toolkit
- FAQs
- Investors’ Queries
-
-
Accounts
- Al Hayrat Account
- Current Account
- Fixed Deposits Account
- Money Maker Account
- Salary Transfer Account
- Starmaker Account
- Super Saver Account
Al Wajaha
- Overview
BBK Lite
- Overview
NRI
- NRI Services
Debit Cards
- Classic
- Gold
- Signature
- Infinite
Self-service Banking
- ATM
- Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- Debit Card Issuance Machines
Foreign Exchange
- Remittance
- American Express
-
Insurance
- Home Secura
- Motor Secura
- Travel Secura
Investment
- Bonds
- IPO
- Mutual Funds
- Real Estate Investment
-
Branches and Self-Service
- Branches
- ATM
- Deposit Machines
- Debit Card Issuance Machines
- Corporate Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- BBK Virtual
Contactless Payments
- Apple Pay
- Samsung Wallet
- Garmin Pay
- Fitbit Pay
More Ways to Bank
- New Mobile app & Online Banking
- eStatements
- BBK BanKey
- Corporate Deposit Card
- Debit Card
- Telebanking
- Open Banking
- AFAQ Payment System
Sign Language
- Sign Language Directory
-
-
-
Accounts
- Business Current Account
- Business Fixed Deposit Account
Cash Management
- Bankey eBanking
- Payroll Services
- Deposit Machines
- POS Credimax
- Remittance
-
Working Capital Finance
- Overdraft
- Cheque discounting
- Short Term Loans
Long Term Finance
- Project Finance
- Assets Finance
- Real estate Finance
-
Corporate Banking
- Government Affairs
- Real Estate, Services and Trading
- Contracting, Building Material, and Manufacturing
International Banking
- Overview
- Services
- NRI
- Offshore Branches
- Representative offices
Enterprise Banking
- Overview
-
-
-
-
FINANCIAL NEWS
Hikma Pharm acquires 98.09 percent of EUP share capital
09 Sep 2015
(MENAFN) Hikma Pharmaceuticals plc, the fast growing multinational pharmaceutical group, said it will acquire 98.09 percent of the share capital of EIMC United Pharmaceuticals (EUP).
Egypt’s EUP is a pharmaceutical manufacturing company specializing in oncology products. The acquisition of EUP strengthens Hikma’s position in the large and fast growing Egyptian market.
Hikma’s operations are conducted through three businesses: “Branded”, “Injectables” and “Generics” based mainly in MENA region. In 2014, it achieved revenues of USD1.48 billion and profit of USD299 million.
More News
05 Aug 2024
With the support of BBK, BIBF and BJA hold a graduation ceremony for journalists completing the training program
09 Jun 2024
BBK Successfully Closes USD Benchmark Bond Offering at $500 Million, in Collaboration with a Consortium of Regional and International Banks.
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more